newsfilter
← Latest News
Business Wire·

Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck

First patient dosed in the lead collaboration program triggers a $10 million milestone payment to Janux Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad